CS201752B1 - Strain of microorganism streptomyces galilaeus 947 ccm 3320 - Google Patents
Strain of microorganism streptomyces galilaeus 947 ccm 3320 Download PDFInfo
- Publication number
- CS201752B1 CS201752B1 CS122379A CS122379A CS201752B1 CS 201752 B1 CS201752 B1 CS 201752B1 CS 122379 A CS122379 A CS 122379A CS 122379 A CS122379 A CS 122379A CS 201752 B1 CS201752 B1 CS 201752B1
- Authority
- CS
- Czechoslovakia
- Prior art keywords
- strain
- ccm
- streptomyces galilaeus
- pyrromycinone
- agar
- Prior art date
Links
- 241001467544 Streptomyces galilaeus Species 0.000 title claims description 16
- 244000005700 microbiome Species 0.000 title claims description 5
- RWCVSDKDFSVZNF-KRYGIPSASA-N (1R,2R,4S)-2-ethyl-2,4,5,7,10-pentahydroxy-6,11-dioxo-3,4-dihydro-1H-tetracene-1-carboxylic acid methyl ester Chemical compound O=C1C2=C(O)C=CC(O)=C2C(=O)C2=C1C(O)=C1[C@@H](O)C[C@@](CC)(O)[C@H](C(=O)OC)C1=C2 RWCVSDKDFSVZNF-KRYGIPSASA-N 0.000 claims description 9
- RWCVSDKDFSVZNF-UHFFFAOYSA-N epsilon-Pyrromycinone Natural products O=C1C2=C(O)C=CC(O)=C2C(=O)C2=C1C(O)=C1C(O)CC(CC)(O)C(C(=O)OC)C1=C2 RWCVSDKDFSVZNF-UHFFFAOYSA-N 0.000 claims description 7
- 229920001817 Agar Polymers 0.000 description 10
- 239000008272 agar Substances 0.000 description 10
- RACGRCLGVYXIAO-YOKWENHESA-N aklavinone Chemical compound O=C1C2=C(O)C=CC=C2C(=O)C2=C1C(O)=C1[C@@H](O)C[C@@](CC)(O)[C@H](C(=O)OC)C1=C2 RACGRCLGVYXIAO-YOKWENHESA-N 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 5
- 239000000758 substrate Substances 0.000 description 5
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 4
- 229920002472 Starch Polymers 0.000 description 4
- 229910052799 carbon Inorganic materials 0.000 description 4
- 238000004040 coloring Methods 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 239000008107 starch Substances 0.000 description 4
- 235000019698 starch Nutrition 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 229940041514 candida albicans extract Drugs 0.000 description 3
- 238000004587 chromatography analysis Methods 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 239000002207 metabolite Substances 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 239000000049 pigment Substances 0.000 description 3
- 229930000044 secondary metabolite Natural products 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 239000001058 brown pigment Substances 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 229930182470 glycoside Natural products 0.000 description 2
- 150000002338 glycosides Chemical class 0.000 description 2
- 239000002054 inoculum Substances 0.000 description 2
- 230000003505 mutagenic effect Effects 0.000 description 2
- 150000002823 nitrates Chemical class 0.000 description 2
- 239000002689 soil Substances 0.000 description 2
- 238000010186 staining Methods 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- 238000004809 thin layer chromatography Methods 0.000 description 2
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N 2,3,4,5-tetrahydroxypentanal Chemical compound OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
- 241000186361 Actinobacteria <class> Species 0.000 description 1
- 101000775660 Anarhichas lupus Type-3 ice-structuring protein 1.5 Proteins 0.000 description 1
- 101000775628 Anarhichas lupus Type-3 ice-structuring protein 1.9 Proteins 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- 101710128742 Cytochrome b6-f complex iron-sulfur subunit 2 Proteins 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 101100114828 Drosophila melanogaster Orai gene Proteins 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 229920001202 Inulin Polymers 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 206010028400 Mutagenic effect Diseases 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- IOVCWXUNBOPUCH-UHFFFAOYSA-N Nitrous acid Chemical compound ON=O IOVCWXUNBOPUCH-UHFFFAOYSA-N 0.000 description 1
- 101000643905 Nostoc sp. (strain PCC 7120 / SAG 25.82 / UTEX 2576) Cytochrome b6-f complex iron-sulfur subunit 3 Proteins 0.000 description 1
- 240000007817 Olea europaea Species 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 101000775697 Pseudopleuronectes americanus Ice-structuring protein 3 Proteins 0.000 description 1
- 101000775692 Pseudopleuronectes americanus Ice-structuring protein 4 Proteins 0.000 description 1
- 241001406782 Rhamnosa Species 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 241001222097 Xenocypris argentea Species 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000008351 acetate buffer Substances 0.000 description 1
- GZCGUPFRVQAUEE-KCDKBNATSA-N aldehydo-D-galactose Chemical compound OC[C@@H](O)[C@H](O)[C@H](O)[C@@H](O)C=O GZCGUPFRVQAUEE-KCDKBNATSA-N 0.000 description 1
- GZCGUPFRVQAUEE-KVTDHHQDSA-N aldehydo-D-mannose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)C=O GZCGUPFRVQAUEE-KVTDHHQDSA-N 0.000 description 1
- PYMYPHUHKUWMLA-VPENINKCSA-N aldehydo-D-xylose Chemical compound OC[C@@H](O)[C@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-VPENINKCSA-N 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 239000003817 anthracycline antibiotic agent Substances 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 230000001851 biosynthetic effect Effects 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- WORJEOGGNQDSOE-UHFFFAOYSA-N chloroform;methanol Chemical compound OC.ClC(Cl)Cl WORJEOGGNQDSOE-UHFFFAOYSA-N 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 125000005639 glycero group Chemical group 0.000 description 1
- 238000005858 glycosidation reaction Methods 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229910017053 inorganic salt Inorganic materials 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 1
- 229940029339 inulin Drugs 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- BJHIKXHVCXFQLS-UYFOZJQFSA-N keto-D-fructose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C(=O)CO BJHIKXHVCXFQLS-UYFOZJQFSA-N 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 229960001855 mannitol Drugs 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 239000003471 mutagenic agent Substances 0.000 description 1
- 231100000707 mutagenic chemical Toxicity 0.000 description 1
- 231100000243 mutagenic effect Toxicity 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000001053 orange pigment Substances 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 238000010187 selection method Methods 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Description
Vynález se týká nového průmyslového mikroorganismu Streptomyces galilaeus 947, CCM 3320 produkujícího ε-pyrromycinon, který lze využít pro synthesu protinádorových anthracyklinových antibiotik.The invention relates to a novel industrial microorganism Streptomyces galilaeus 947, CCM 3320 producing ε-pyrromycinone, which can be used for the synthesis of antitumor anthracycline antibiotics.
Standardní kmen Streptomyces galilaeus JA 3043 (ZIMET, Jena) produkuje směs biologicky aktivních glykosidů ε-pyrromycinonu a aklavinonu. U mutantního kmene Streptomyces galilaeus 947 došlo genetickým. zásahem k bloku v glykosidačním stupni biosynthesy těchto látek vedoucím k akumulaci volných aglykonů. Jako hlavní metabolit je produkován ε-pyrromycinon; v minoritním množství jsou tvořeny aklavinon, ει-pyrromycinon a 7-deoxy- a bisanhydroderiváty ε-pyrromycinonu a aklavinonu.The standard Streptomyces galilaeus strain JA 3043 (ZIMET, Jena) produces a mixture of biologically active glycosides ε-pyrromycinone and aclavinone. A mutant strain of Streptomyces galilaeus 947 occurred genetically. by interfering with the block in the glycosidation stage of the biosynthesis of these compounds leading to the accumulation of free aglycons. Ε-pyrromycinone is produced as the main metabolite; minor amounts of aclavinone, ε-pyrromycinone and 7-deoxy- and bisanhydroderivatives of ε-pyrromycinone and aclavinone are formed.
Kmen Streptomyces galilaeus 947 byl získán ze standardního kmene Streptomyces galilaeus JA 3043 pětistupňovým selekčním postupem za použití přirozené selekce a účinku mutagenů. Kmen byl isolován z populace po účinku kyseliny dusité a jeho variabilita byla snížena přirozenou selekcí. Kyselina dusitá byla aplikována jako 0,05 M NaNO2 v 0,2 M acetátovém pufru (pH 4,0) po dobu 25 min. Při této dávce mutagenu bylo usmrceno 99,93 % konidií v suspensi. Změněná biosynthetická aktivita mutantního kmene byla zjištěna tenkovrstevnou chromatografií metabolitů submersní kultury.The Streptomyces galilaeus strain 947 was obtained from the standard Streptomyces galilaeus JA 3043 strain by a five-step selection procedure using natural selection and mutagenic effects. The strain was isolated from the nitric acid population and its variability was reduced by natural selection. Nitrous acid was applied as 0.05 M NaNO 2 in 0.2 M acetate buffer (pH 4.0) for 25 min. At this dose of mutagen, 99.93% of conidia in suspension were killed. The altered biosynthetic activity of the mutant strain was determined by thin layer chromatography of submersible culture metabolites.
Dále je uvedena charakteristika vlastností mutantního kmene Streptomyces galilaeus 947, jehož vzorek kultury je uložen ve Sbírce kultur mikroorganismů University J. E. Purkyně v Brně pod-číslem CCM 3320.The characteristics of a mutant strain of Streptomyces galilaeus 947, whose sample of culture is deposited in the Collection of Cultures of Microorganisms of the University of J. E. Purkyně in Brno under the number CCM 3320, are given below.
1. Morfologická charakteristika1. Morphological characteristics
Při kultiváci na ovesném agaru (ISP 3), na půdě s anorganickými solemi a škrobem (ISP 4) a na půdě s kvasinkovým a sladovým výtažkem (ISP 2) tvořil mutantní kmen 947 vzdušné mycelium se sporofory monopodiálně větvenými, s otevřenými spirálami se 4—6 závity. Vzdušné mycelium kmene 947 bylo méně vyvinuto než u standardního kmene JA 3043. Na asparaginové půdě s glycerolem (ISP 5), na tyrosinovém agaru (ISP 7), na Benettově agaru (Waksman S. A. The Actinomycetes. Chronica Botanica, Waltham, Mass., USA, 1950) a na substrátu s minerálním zdrojem dusíku (Gause G. F. et al., Zur Klassifizierung der Actinomyceten. VEB G. Fischer, Jena, 1958) tvořil standardní kmen dobře vyvinuté vzdušné mycelium, zatímco u mutantního kmene byly jen stopy vzdušného mycelia.In oat agar (ISP 3), inorganic salt and starch (ISP 4), and yeast and malt extract (ISP 2) cultivation, the mutant strain 947 formed an airy mycelium with sporophores monopodially branched, with open spirals of 4— 6 threads. Aerial mycelium strain 947 was less developed than wild type JA 3043. On asparagine soil with glycerol (ISP 5), on tyrosine agar (ISP 7), on Benett agar (Waksman SA The Actinomycetes. Chronica Botanica, Waltham, Mass., USA) (1950) and on a substrate with a mineral nitrogen source (Gause GF et al., Zur Klassifizierung der Actinomyceten. VEB G. Fischer, Jena, 1958) formed a standard strain of well-developed aerial mycelium, whereas the mutant strain contained only traces of aerial mycelium.
Ve tvaru a v povrchu spor nebyly podstat201752The shape and surface of the spores were not the essence of201752
Tabulka I: Zbarvení substrátového mycelia, vzdušného mycelia a difundujících pigmentů u mutantního kmene Streptomyces galilaeus 947 CCM 3320 a standardního kmene Streptomyces galilaeus JA 3043 po 21 dnech kultivace při 28 °C.Table I: Staining of substrate mycelium, aerial mycelium and diffusing pigments in mutant strain Streptomyces galilaeus 947 CCM 3320 and wild type strain Streptomyces galilaeus JA 3043 after 21 days of culture at 28 ° C.
vzdušné mycelium málo vyvinuto né rozdíly mezi mutantním a standardním kmenem. Oba kmeny tvořily spory s hladkým povrchem.aerial mycelium little developed differences between mutant and standard strain. Both strains formed spores with a smooth surface.
2. Zbarvení kultur2. Coloring of cultures
Pigmentace vzdušného a substrátového mycelia byla hodnocena podle Prauserovy stupnice (Z. Allg. Mikrobiol., 4:95, 1964) po 2, 4, 7, 14 a 21 dnech kultivace.The pigmentation of airborne and substrate mycelium was evaluated according to the Prauser scale (Z. Allg. Mikrobiol., 4:95, 1964) after 2, 4, 7, 14 and 21 days of culture.
a) Zbarvení vzdušného myceliaa) Coloring of aerial mycelium
Vzdušné mycelium standardního i mutantního kmene bylo zbarveno v různých odstínech šedé barvy. Bílé mycelium bylo pozorováno jen u mladých dosud nevyvinutých kultur.The aerial mycelium of both the standard and mutant strains were stained in various shades of gray. White mycelium was observed only in young, undeveloped cultures.
b) Zbarvení substrátového myceliab) Staining of the substrate mycelium
Výsledky získané po 21 dnech kultivace u obou kmenů jsou uvedeny v tabulce I.The results obtained after 21 days of culture in both strains are shown in Table I.
c) Zbarvení difunduj ících pigmentůc) Coloring of diffusing pigments
Mutantní kmen 947 a standardní kmen JAMutant strain 947 and standard strain JA
3043 tvořily na ovesném agaru a na Benettově agaru světle hnědý pigment a na agaru s kvasinkovým a sladovým výtažkem oranžový pigment.3043 formed a light brown pigment on oat agar and on Benett's agar and an orange pigment on yeast and malt extract agar.
3. Fysiologické charakteristiky3. Physiological characteristics
a) Produkce melaninových pigmentů(a) Production of melanin pigments
Na peptonové půdě se železem a na tyrosinovém médiu tvořil mutantní kmen stejně jako standardní kmen intensivní černohnědý pigment.On the peptone broth with iron and on the tyrosine medium, the mutant strain as well as the standard strain formed an intense black-brown pigment.
b) Asimilace zdrojů uhlíku(b) Assimilation of carbon sources
Výsledky získané u oboň kmenů po 14 dnech kultivace na různých zdrojích uhlíku jsou uvedeny v tabulce II.The results obtained for both strains after 14 days of cultivation on different carbon sources are shown in Table II.
Tabulka II: Asimilace zdrojů uhlíku u mutantního kmene Streptomyces galilaeus 947 CCM 3320 a u standardního kmene Streptomyces galilaeus JA 3043 po 14 dnech kultivaceTable II: Assimilation of carbon sources in mutant strain Streptomyces galilaeus 947 CCM 3320 and in standard strain Streptomyces galilaeus JA 3043 after 14 days of culture
U-) ¥ŮSt + slabý růst +-(- dobrý růst 4--j-+ velmi dobrý růstU-) Ů ŮST + weak growth + - (- good growth 4 - j- + very good growth
c) Ztekucování želatiny, redukce nitrátů, tvorba redukujících cukrů a odbourávání škrobu.(c) Liquefaction of gelatin, reduction of nitrates, formation of reducing sugars and degradation of starch.
Mutantní i standardní kmen ztekucovaly želatinu, redukovaly nitráty, štěpily sacharosu na redukující cukry a odbourávaly škrob.Both the mutant and wild-type strains liquefied gelatin, reduced nitrates, cleaved sucrose to reducing sugars, and degraded starch.
4. Produkce sekundárních metabolitů4. Production of secondary metabolites
Jako dalšího kritéria pro charakteristiku mutantního kmene Streptomyces galilaeus 947 se použila chromatografické analysa produkce sekundárních metabolitů v submersních kulturách, která je nej průkaznějším ukazatelem rozdílu mezi mutantním a standardním kmenem.As a further criterion for the characterization of the mutant strain Streptomyces galilaeus 947, a chromatographic analysis of the production of secondary metabolites in submersible cultures was used, which is the most conclusive indicator of the difference between the mutant and the standard strain.
a) Kultivace(a) Cultivation
Submersní kultivace byly prováděny na reciproké třepačce (frekvence 1,6 Hz, amplituda 80 mm) při 28 °C v 500 ml varných baňkách, plněných 60 ml půdy. Inokulační baňky byly očkovány sporovým inokulem z kultury na agaru s kvasinkovým a sladovým výtažkem a kultivovány 24 h na půdě následujícího složení:Submerged cultures were performed on a reciprocating shaker (frequency 1.6 Hz, amplitude 80 mm) at 28 ° C in 500 ml beakers filled with 60 ml of soil. The inoculation flasks were inoculated with spore inoculum from yeast and malt extract agar culture and cultured for 24 hours on the following composition:
sojová mouka glukosa corn-steepsoya flour glucose corn-steep
CaCO3 CaCO 3
NaClNaCl
2,0 % 1,0 % 0,25 «/ /02.0% 1.0% 0.25%
0,3 %0.3%
0,5% pH: 6,5 Fermentační baňky byly očkovány 5 % inokula a kultivovány 96 h na půdě stejného složení se zvýšeným obsahem glukosy (2,5 %).0.5% pH: 6.5 The fermentation flasks were inoculated with 5% inoculum and cultured for 96 hours on the same composition with increased glucose content (2.5%).
b) Chromatografie(b) Chromatography
Produkce sekundárních metabolitů byla sledována tenkovrstevnou chromatografii na silikagelu impregnovaném NaHCO3 (10 : 1) v systému chloroform-methanol (49 :1).Secondary metabolite production was monitored by thin layer chromatography on silica gel impregnated with NaHCO 3 (10: 1) in a chloroform-methanol (49: 1) system.
Mycelium bylo odfiltrováno a extrahováno methanolem okyseleným HC1 (pH 2,5-3,5), extrakt byl neutralizován amoniakem, zfiltrován a odpařen za vakua. Odparek byl rozpuštěn v chloroformu a použit pro chromatografii.The mycelium was filtered off and extracted with HCl acidified methanol (pH 2.5-3.5), the extract was neutralized with ammonia, filtered and evaporated in vacuo. The residue was dissolved in chloroform and used for chromatography.
U standardního kmene Streptomyces galilaeus JA 3043 byl detegován komplex glykosidů ε-pyrromycinonu a aklavinonu spolu se 7-deoxy- a bisanhydroderiváty těchto aglykonů. Mutantní kmen Streptomyces galilaeus 947 neprodukuje glykosidy, jako hlavní metabolit akumuluje volný ε-pyrromycinon a v minoritním množství produkuje aklavinon, εί-pyrromycinon, 7-deoxy- a bisanhydroderiváty ε-pyrromycinonu a aklavinonu.A complex strain of ε-pyrromycinone and aclavinone together with the 7-deoxy- and bisanhydroderivatives of these aglycons was detected in the standard Streptomyces galilaeus JA 3043 strain. The mutant strain Streptomyces galilaeus 947 does not produce glycosides, it accumulates free ε-pyrromycinone as the main metabolite and produces minor amounts of aclavinone, εί-pyrromycinone, 7-deoxy- and bisanhydroderivatives of ε-pyrromycinone and aclavinone.
Claims (1)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CS122379A CS201752B1 (en) | 1979-02-23 | 1979-02-23 | Strain of microorganism streptomyces galilaeus 947 ccm 3320 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CS122379A CS201752B1 (en) | 1979-02-23 | 1979-02-23 | Strain of microorganism streptomyces galilaeus 947 ccm 3320 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CS201752B1 true CS201752B1 (en) | 1980-11-28 |
Family
ID=5346078
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CS122379A CS201752B1 (en) | 1979-02-23 | 1979-02-23 | Strain of microorganism streptomyces galilaeus 947 ccm 3320 |
Country Status (1)
| Country | Link |
|---|---|
| CS (1) | CS201752B1 (en) |
-
1979
- 1979-02-23 CS CS122379A patent/CS201752B1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Maskey et al. | Himalomycin A and B: isolation and structure elucidation of new fridamycin type antibiotics from a marine Streptomyces isolate | |
| US4970198A (en) | Antitumor antibiotics (LL-E33288 complex) | |
| Takiguchi et al. | Milbemycins, a new family of macrolide antibiotics: fermentation, isolation and physico-chemical properties | |
| US5108912A (en) | Antitumor antibiotics (LL-E33288 complex) | |
| Tomita et al. | Tetrocarcins, Novel Antitumor Antibiotics I. Producing Organism, Fermentation and Antimicrobial Activity | |
| NO148959B (en) | PROCEDURE FOR THE PREPARATION OF TUMOR-EFFECTIVE ANTACYCYLICOSIDE ANTIBIOTICS, MA MA 144 | |
| US4713371A (en) | Anthracycline derivatives and their use as cytostatics | |
| Cassinelli et al. | Preparation and biological evaluation of 4-O-demethyldaunorubicin (carminomycin I) and of its 13-dihydro derivative | |
| Yoshimoto et al. | New anthracycline metabolites from mutant strains of Streptomyces galilaeus MA144-M1 I. Isolation and characterization of various blocked mutants | |
| Blumauerová et al. | Studies on the production of daunomycinonederived glycosides and related metabolites in Streptomyces coeruleorubidus and Streptomyces peucetius | |
| JOHDO et al. | Anthracycline metabolites from Streptomyces violaceus A262 I. Isolation of antibiotic-blocked mutants from Streptomyces violaceus A262 | |
| Blumauerova et al. | Biotransformations of anthracyclinones in Streptomyces coeruleorubidus and Streptomyces galilaeus | |
| US4383037A (en) | Process to produce anthracycline glycosides | |
| CS201752B1 (en) | Strain of microorganism streptomyces galilaeus 947 ccm 3320 | |
| NAGASAWA et al. | SAKYOMICINS A, B, C AND D: NEW QUINONE-TYPE ANTIBIOTICS PRODUCED BY A STRAIN OF NOCARDIA TAXONOMY, PRODUCTION, ISOLATION AND BIOLOGICAL PROPERTIES | |
| Cooper et al. | Macrolactams: two novel homologous series of compounds produced by Actinomadura sp. SCC 1778 | |
| Blumauerová et al. | Intra-and interspecific cosynthetic activity of mutants of Streptomyces coeruleorubidus and Streptomyces galilaeus impaired in the biosynthesis of anthracyclines | |
| EP0187049B1 (en) | Micromonospora microorganisms and macrolide antibiotic production therewith | |
| Blumauerová et al. | Mutants of Streptomyces coeruleorubidus impaired in the biosynthesis of daunomycinone glycosides and related metabolites | |
| HOSHINO et al. | Microbial conversion of anthracycline antibiotics III. Glycosidation of natural and chemically synthesized anthracycline aglycones | |
| Blumauerová et al. | Effect of DL-ethionine on the biosynthesis of anthracyclines in Streptomyces coeruleorubidus | |
| Omura et al. | PRODUCTION OF MYCAROSYL PROTYLONOLIDE BY A MYCAMINOSE IDIOTROPH FROM THE TYLOSINPRODUCING STRAIN STREPTOMYCES FRADIAE KA-427 | |
| Králavcová et al. | The effect of 5, 5-diethylbarbituric acid on the biosynthesis of anthracyclines in Streptomyces galilaeus | |
| Blumauerová et al. | Improved yields of daunomycinone glycosides in developmental mutants of Streptomyces coeruleorubidus | |
| US6878535B2 (en) | Process for producing soyasapogenol B and novel microorganisms |